hrp0095p2-221 | Pituitary, Neuroendocrinology and Puberty | ESPE2022

Clinical and laboratory assessment of children with central precocious puberty during and after stoppage of treatment with gonadotropin-releasing hormone agonist

El-Hawary Amany , Elsharkawy Ashraf , Abdelrazik Wafaa , Aboelenin Hadil

Central precocious puberty (CPP) caused by early maturation of the hypothalamic–pituitary–gonadal axis, resulting in early appearance of secondary sexual characteristics That affects children’s normal life and their adulthood’s final height. GnRH agonist therapy inhibits stimulating effects of endogenous GnRH by desensitizing hypophyseal gonadotropic cells and thus acceleration in bone maturation and early puberty is suppressed. So the aim of this longi...